Jenburkt Pharmaceuticals shareholding pattern

JENBURPH

HealthcareSmall

1108

61.30 (-5.24%)
Last updated on 18 Aug, 2025 | 15:29 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Jenburkt Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2025-26
  • 2024-25
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

46.69%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.12%

Retail

53.2%

Others

-0.01%

Total Promoters
MAR '24
47.23%
JUN '24
46.71%
SEP '24
46.71%
DEC '24
46.69%

Jenburkt Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Jenburkt Pharmaceuticals stands at 46.67% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Jenburkt Pharmaceuticals is 0% and 0.12% respectively.

The retail shareholding of the Jenburkt Pharmaceuticals is 53.22%.

Changes in shareholding patterns of Jenburkt Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Jenburkt Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.